Mark P. Arrington

Magleby Cataxinos • Salt Lake City, UT

Claim this Profile

Intellectual Property & Other Complex LitigationReal EstateTax

📧 Contact Mark

Is this your profile?

Claim it for free to update your information and connect with clients.

Claim Profile →

Contact

marrington@sternekessler.com

Phone

866-928-7962

Address

Salt Lake City, UT, 84101, US

Professional

Bar Admissions

U.S. Patent and Trademark Office

Tier

Tier 2

About

Mark P. Arrington is a seasoned attorney at Magleby Cataxinos in Salt Lake City, Utah, specializing in intellectual property and complex litigation. With a robust background in both law and the sciences, Mark offers a unique blend of expertise in patents, trademarks, copyrights, and trade secrets, ensuring comprehensive representation for clients navigating the intricacies of intellectual property law. Mark's extensive experience encompasses counseling and strategic planning, due diligence, and transactional licensing, making him a trusted advisor for businesses of all sizes. His academic credentials include a J.D. from The S.J. Quinney College of Law at The University of Utah, where he graduated with honors, a Ph.D. in Organic Chemistry from Colorado State University, and a Bachelor of Science in Chemistry from UC San Diego. Additionally, he served as an Eli-Lilly Post Doctorate Fellow at The Ohio State University. Dedicated to providing tailored solutions, Mark is committed to understanding the unique needs of each client, guiding them through the complexities of intellectual property and litigation with confidence and clarity. Serving a diverse clientele throughout the Salt Lake City area and beyond, Mark P. Arrington stands out as a knowledgeable and dependable legal partner for those seeking to protect their intellectual assets and navigate the complexities of the legal landscape.

Credentials

Education

Recognition & Involvement

Publications

["Cinnoline Derivatives as phosphodiesterase 10 inhibitors, their preparation, pharmaceutical compositions, and use in therapy , WO2007098169 , 2007", "Cetirizine and loratadine-based antihistamines with 5-lipoxygenase inhibitory activity. [Bioorg. Med. Chem. Lett., 14(22): 5591-5594], 2004", "Constraining of Small-Ring Cyclic Ether Triads by Stereodefined Spiroannulation to an Inositol Orthoformate Platform. Solution-and Gas-Phase Alkali Metal Binding Affinities for Three-to-Five-Membered Ring Structural Combinations. [J. Org. Chem. 66(25): 8629-8639], 2001", "Enantioselective double michael addition/cyclization with an oxygen-centered nucleophile as the first step in a concise synthesis of natural (+)-asteriscanolide. [J. Am. Chem. Soc. 122(12): 2742-2748], 2000", "Asymmetric Synthesis of the Core Cyclopentane of Viridenomycin. [Chem. Comm., 15.1371-1372], 1999", "Modified cinchona alkaloid ligands: Improved selectivities in the osmium tetroxide catalyzed asymmetric dihydroxylation (AD) of terminal olefins. [Tetrahedron Lett. 34(46): 7375-7378], 1993", "Synthesis and preliminary evaluation of aryl arenesulfonate esters as potential intermediate temperature fluids [Indus. & Eng. Chem. Res. 34(3): 981-986], 1995"]

Associations

University of Utah National Intellectual Property Moot Court team

Updated: Mar 14, 2026